Hostetter Named Chair of Pediatrics
Margaret "Peggy Hostetter, MD, has been selected to serve as chair of the Department of Pediatrics at the UC College of Medicine, chief medical officer of Cincinnati Childrens, and director, Cincinnati Childrens Research Foundation.
Upon approval by the UC Board of Trustees, Hostetter will serve as the eighth B.K. Rachford Memorial Chair in Pediatrics. Her appointment concludes a national search launched in 2013 and led by Louis Muglia, MD, PhD, and Lori Stark, PhD.
Hostetter joined Cincinnati Childrens in 2010 as the Albert B. Sabin Professor and director, Division of Infectious Diseases, Cincinnati Childrens Hospital Medical Center and University of Cincinnati College of Medicine. Prior to joining Cincinnati Childrens, she served as Jean McLean Wallace Professor and chair of the Department of Pediatrics at Yale School of Medicine and physician-in-chief at Yale New Haven Childrens Hospital.
Hostetter is a Toledo, Ohio, native, a graduate of Denison University and Baylor College of Medicine. She completed her residency and fellowship at Childrens Hospital Boston. She is the proud mother of two children, Mayme Kendrick Hostetter and John Heard Hostetter.
In a memo to faculty and staff, Dean of the College of Medicine Thomas Boat, MD, wrote, "we are confident that Dr. Hostetter possesses the leadership, intellect and vision to help Cincinnati Childrens continue to develop as a world-class clinical care, teaching and research institution. As our partner, and yours, we know she will help us shape the future of child health through innovative models of care and research that span discovery, clinical and translational outcomes, as well as health services.
Hostetter will officially begin her role on July 1, assuming the position from Arnold Strauss, MD, who has led the department of pediatrics since 2007. Strauss will remain with Cincinnati Childrens and will continue to serve in a strategic and programmatic role.
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.